Reducing mortality and morbidity in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (stem) Cell (MSC) therapy - achieving global consensus and visibility for cellular host-directed therapies

Alimuddin Zumla, Fu-Sheng Wang, Giuseppe Ippolito, Nicola Petrosillo, Chiara Agrati, Esam I Azhar, Sherif A El-Kafrawy, Mohamed Osman, Laurence Zitvogel, Franco Locatelli, Ellen Gorman, Cecilia O'Kane, Danny Mcauley, Markus Maeurer

Research output: Contribution to journalArticlepeer-review

13 Citations (Scopus)
24 Downloads (Pure)

Fingerprint Dive into the research topics of 'Reducing mortality and morbidity in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (stem) Cell (MSC) therapy - achieving global consensus and visibility for cellular host-directed therapies'. Together they form a unique fingerprint.

Medicine & Life Sciences